Organization: Health Canada
Year: 2021
Month: January
Request Number: A-2020-000718
Request Summary: Adverse Reaction Report (AER) for FACTOR VII. Report number: E2B_03132694. ADR for ADDERALL XR: 000911513. ADRs for Amphetamine aspartate monohydrate: E2B_03072094, E2B_03099019. ADR for INTUNIV XR: 000915872. ADRs for MEZAVANT: E2B_03009989, E2B_03021516, E2B_03029508, E2B_03066067, E2B_03069502, E2B_03070574, E2B_03102099, E2B_03108058, E2B_03156394, E2B_03161189. ADRs for VYVANSE: 000738032 000908970, 000910227, 000911429, E2B_03150308.
Disposition: Disclosed in part
Number of pages: 211